Pharmaceutical Related Topics 
Fierce Pharma
SEPTEMBER 20, 2023
ARS Pharmaceuticals learned that lesson the hard way, as the FDA issued a surprise rejection of its anaphylaxis nasal spray Neffy. Positive FDA advisory committee votes aren’t always a blueprint for approval. Positive FDA advisory committee votes aren’t always a blueprint for approval.
Fierce Pharma
MARCH 28, 2024
[Yangzhou, China - March 26, 2024] - Aurisco Pharmaceutical, a leading global pharmaceutical company, is excited to announce the completion of its investment in cGMP peptide manufacturing capacity | Aurisco Pharmaceutical Launches State-of-the-Art Manufacturing Facility for GLP-1 Peptides
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
SEPTEMBER 1, 2023
Marlex Pharmaceuticals of New Castle, Delaware, is recalling two lots of digoxin tablets at the 0.125-mg and 0.25-mg When it comes to heart failure medication, a labeling mix-up can have dire consequences. mg dose, and vice versa.
Pharmaceutical Technology
MAY 2, 2024
From Merck & Co to Sanofi, Pharmaceutical Technology lists the leading pharmaceutical companies spending the most on R&D in 2023.
European Pharmaceutical Review
JULY 9, 2024
Researchers have developed an ultrasensitive analytical method for quantifying nitrite quantity in process water for pharmaceutical products. The post Chromatography analysis for nitrosamine quantitation in pharmaceutical manufacturing water appeared first on European Pharmaceutical Review. Kumar et al.
European Pharmaceutical Review
APRIL 18, 2024
What are the three main challenges of monitoring pharmaceuticals in the environment? Andreas Häner (AH): Roche, along with other pharmaceutical companies, acknowledges concerns about pharmaceuticals in the environment (PiE). A well-designed wastewater sampling plan will ensure that representative samples are collected.
European Pharmaceutical Review
APRIL 25, 2024
Research on the global pharmaceutical parenteral packaging market by InsightAce Analytic Pvt. Regionally, North America is anticipated to hold a major portion of the pharmaceutical parenteral packaging market, according to the report. has predicted that the sector will value $18.85 billion by 2031. This is aligned with a CAGR of 4.47
Expert insights. Personalized for you.
289 
Let's personalize your content